Skip to main content

Factsheet: Waldenstrom’s macroglobulinaemia (WM) and COVID-19: Are people with WM more at risk of complications?

Dr Dima El-Sharkawi, WMUK trustee and Consultant Haematologist at the Royal Marsden Hospital, London, looks to answer some of the questions currently being asked of doctors and nurses in clinic consultations regarding how much people with WM should still be avoiding others.

Can I see my grandchildren? Can I go back to work? Is it ok for my partner to go back to work? Is it ok to go out for a meal? Should I delay my treatment? Can you quantify my risk?

Only a few months ago, you would have all been told that you are in the “clinically extremely vulnerable group” and that you should avoid all people outside your household contacts and “shield”. Now that shielding has been paused by the UK government as the rate of people with SARS-CoV-2 in the UK is going down, a large part of my clinic consultations with patients is taken up by questions regarding how much they should still be avoiding others, with the questions above being some of the hundreds doctors and nurses are asked every week.

 

Follow the link below to read the full factsheet.

Agile Social Share

Share this page